News

News

Icon LISA News = LISA News
29.08.2022
Valneva Reports Further Positive Phase 3 Immunogenicity and the First Heterologous Booster Results for its Inactivated, Adjuvanted COVID-19 Vaccine VLA2001
29.08.2022
WHEN MOTHERS SHUT DOWN THE FATHERS’ GENES IN THE EMBRYO
29.08.2022
Bacteria provide immunity against giant viruses
26.08.2022
Notfallsystem bei Nervenzellen entdeckt
25.08.2022
COVID-19-assoziierte Pilzinfektion: Große internationale Studie identifiziert immunologische Mechanismen und klinische Risikofaktoren
25.08.2022
Neuer Wirkstoff erweitert Therapiespektrum bei Rheumatoider Arthritis
25.08.2022
Vast paleogenetic study reveals insights on migration patterns, the expansion of farming and language development from the Caucasus over western Asia and Southern Europe from the early Copper Age until the late middle ages
24.08.2022
TILT COMPENSATION MAXIMIZES PRECISION IN 2PP 3D-PRINTING
18.08.2022
Valneva Provides Update on IXIARO® Supply Contract with U.S. Department of Defense
18.08.2022
Valneva Initiates Rolling Submission of FDA Biologics License Application for its Single-Shot Chikungunya Vaccine Candidate